Dr. Leslie Cooper, Myocarditis Foundation Co-Founder and Board Member, began researching giant cell myocarditis 
(GCM) in 1993 when there was no treatment other than heart transplant and not many patients lived long enough to receive one. Dr. Cooper developed a treatment regiment using immunosuppressive drugs which increased one year survival to 91%.
One of the people that Dr. Cooper’s research and treatment saved was Hal Stahl when he developed GCM at 47. 19 years later Hal is living a full life due to early diagnosis and Dr. Cooper’s lifesaving cure.
